The corporate group Merz GmbH & Co. KGaA is a leading mid-sized European specialty pharmaceutical company. The company’s prescription research platforms are located in Frankfurt, Germany with core competencies in central nervous system (CNS) and dermatology.
Merz is focused on pharmaceuticals for the treatment of neurological and psychiatric disorders and is a leader in the field of Alzheimer's research.
The company also researches and develops over-the-counter products for the prevention of health problems and the preservation of fitness and well-being.
Total sales within the Merz Group achieved 610.5 million euros for the fiscal year ending June 2008 with the pharmaceutical business making up around 70% of group sales.
Other firms that belong to the Merz GmbH & Co. KGaA family are the writing instruments company Senator, which maintains a leading worldwide position in promotional items, and Merz Dental GmbH, a leading specialty dental company.
The Merz Group employs a staff of 2,289 worldwide and has distributorships or subsidiaries in more than 100 countries.
For more information, visit www.merz.com.